Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Rahul Dalal MD, MPH

Rahul S. Dalal MD, MPH

Instructor in Medicine and Associate Gastroenterologist, Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

Dr. Rahul S. Dalal is Associate Gastroenterologist at the Crohn’s and Colitis Center of Brigham and Women’s Hospital and Instructor in Medicine at Harvard Medical School in Boston, MA. He graduated magna cum laude from Yale University where he majored in molecular biophysics and biochemistry and completed his medical degree at Brown University where he was inducted into the Alpha Omega Alpha Honor Medical Society. He trained in internal medicine at the Hospital of the University of Pennsylvania, where he also completed a certificate program in healthcare quality improvement and patient safety. He completed his gastroenterology and advanced inflammatory bowel disease (IBD) training at Brigham and Women’s Hospital and Harvard Medical School and his MPH degree from the Harvard TH Chan School of Public Health.

Dr. Dalal’s clinical interests include management of complex IBD and his research interests include comparative effectiveness and dose optimization of advanced therapies, pain management, and spondyloarthritis in IBD.

Disclosures

Dr. Dalal has served as a consultant for Centaur Labs, Takeda, and Janssen and has received research grant support from Pfizer and Janssen.